XL# [003]

Related by string. XL# [001] . XL# [002] . XL #S . XLS # * * Exelixis XL# . XL# XL# XL# XL# . XL# XL# . XL# anticancer compounds . XL# XL# XL# . HP Scitex XL# . XL# inhibits . compounds XL# becatecarin . PLC XL# . commercialize XL# . cabozantinib XL# . XL# SAR# . compounds XL# XL# . Samsung SyncMaster XL# . XL# administered orally *

Related by context. Frequent words. (Click for all words.) 70 perifosine 67 FOLOTYN 67 RG# [001] 67 INCB# [002] 66 Phase 1b 66 carfilzomib 66 Phase Ib 64 picoplatin 64 RDEA# 64 antitumor activity 64 MDV# 64 CYT# 63 tivozanib 63 solid tumors 62 MGCD# [002] 62 T DM1 62 pharmacodynamic 62 Phase 2a 62 PLX# 62 Phase 2b study 62 elesclomol 62 ENMD 62 satraplatin 61 Genasense 61 Phase 2b 61 mipomersen 60 Phase III 60 ARRY 60 AZD# 60 Phase 2a clinical 60 Phase IIb 60 hematologic malignancies 60 CUDC 60 Locteron 60 preclinical 60 bavituximab 60 preclinical studies 60 hematological malignancies 60 Phase IIa clinical 60 Phase 2b clinical 59 NSCLC 59 AEZS 59 PRX # 59 Phase III clinical 59 Phase IIb clinical 59 laquinimod 59 dose escalation 59 NKTR 59 investigational compound 59 Vectibix 58 humanized monoclonal antibody 58 APD# 58 pivotal Phase III 58 gefitinib 58 Phase IIa 58 erlotinib 57 Albuferon 57 ANA# 57 Nexavar 57 CK # 57 randomized Phase 57 monotherapy 57 investigational drug 57 alemtuzumab 57 metastatic melanoma 57 oncology indications 57 Prochymal 57 ispinesib 57 dose escalation study 57 bortezomib 56 Hematide 56 ARQ 56 MB# [004] 56 sorafenib 56 Phase IIb trial 56 Phase II 56 antiviral activity 56 ERBITUX 56 sunitinib 56 HCV 56 advanced NSCLC 56 docetaxel 56 preclinical models 56 rituximab 56 ITMN 56 ALKS 56 REVLIMID 56 gemcitabine 55 metastatic colorectal cancer 55 tolerability profile 55 MT# [002] 55 pharmacokinetic profile 55 CB# [002] 55 TMC# [001] 55 hepatocellular carcinoma 55 pivotal Phase 55 taxane 55 PROVENGE 55 SPP# [001] 55 ipilimumab 55 Ceplene

Back to home page